Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Advancing Metabolic Research in NASH, Obesity, and Cachexia Through Pfizer’s ASPIRE Program
Did you know that certain metabolic diseases are connected to one another by underlying biological factors? Non-alcoholic steatohepatitis (NASH), obesity, and cachexia are directly linked with heart health, and together they constitute a global public health concern that risks reaching epidemic proportions. Pfizer is working to discover new medicines to help solve the significant patient needs associated with these conditions, but we recognize that no one company will be able to...
Bringing Together Diverse Organizations to Strive for Health Equity
As a Black woman who grew up living in subsidized housing in the U.S., I know what it means to live in a world where healthcare is not equal, and not trusted. Like so many others, I have family and friends along the health spectrum who have little interest in going to the doctor because they don’t feel seen or heard. This well-earned lack of trust has led some to decide against receiving the COVID-19 vaccine, among other healthcare services and interventions. I know firsthand the work that...
Migraine in the Workplace and Creating a Safe Space
One billion people worldwide live with migraine; that’s about one in seven. At those odds, there’s a high probability that each of us works with someone who experiences migraine. And if you’re an employer, this could mean that migraine in the workplace could have a significant impact on your workforce.Migraine is a debilitating neurological disease that causes intense pain in the head, as well as other sensory and/or motor dysfunction. Migraine attacks usually include symptoms like nausea...
August Social Media Round-Up—Financial Update, World Humanitarian Day, RSV Vaccine
August typically brings two things: the dog days of summer and a lot of vacations! Social media tends to be a little quieter than usual, but that doesn’t mean there wasn’t plenty of activity on the Pfizer side of things. Our CEO provided a financial update, we celebrated World Humanitarian Day, and approvals for a pair of important vaccines. Catch up below. FROM OUR LEADERSHIP CEO Albert Bourla provides an update on Pfizer’s financial performance in the 2nd quarter: https://www.linkedin.com...
Behind the Migraine: Pfizer Colleagues Share Their Stories
We’ve all heard it before: “Migraine is more than just a headache.” But is it really understood? Some talk about the burden of migraine—the blur of pain, vice-like pressure, nausea, insomnia, and even vertigo—but most don’t. Migraine is a disabling neurological disease with different symptoms and treatment approaches compared to other headache disorders. An estimated 40 million people in the United States and more than 1 billion people around the world experience migraine attacks.1,2 So, at...
Race Against Resistance: Pfizer takes on AMR
A new film produced for Pfizer by BBC StoryWorks Commercial Productions puts the spotlight on the threat of antimicrobial resistance (AMR), a health crisis with global, and personal, impact. "Race Against Resistance” explores how the rise of antibiotic resistance, the process by which bacteria adapt and mutate to avoid the very drugs designed to kill them, is threatening to undo almost 100 years of progress in medicine. “Race Against Resistance” shows what’s being done to tackle this global...
July Social Media Round-Up—Rocky Mount Update, Rady Johnson Honored, and Vaccine Progress
On July 20, a tornado touched down in North Carolina, injuring 16 people and damaging a Pfizer plant in Rocky Mount, one of the largest manufacturers of sterile injectable drugs in the world. This month’s social media round-up kicks off with a statement from CEO Albert Bourla about the tornado and its impact on Pfizer. In other news, we also announced a new partnership in drug discovery, helped our summer workers settle in, and saw positive results in vaccine development. Catch up below. FRO...
Pfizer’s Social Media Round-Up—June Edition
As a Fortune 50 company at the forefront of healthcare and science, Pfizer leadership consistently leads the conversation, drives discussion, and impacts markets. It can be tough to keep up with the constant flow of content as the company, our executives, and our initiatives make news online, in the business world, and in our lives. So, in this new monthly series, we’ll help you stay abreast of some of the ways Pfizer is breaking through the noise, by highlighting some of our thought leaders’...
Pfizer Joins Annual Brunch Run to Support Cancer Support Non-Profit Imerman Angels
As patients, family members, caregivers, and friends, it’s likely we’ve each been affected in some way by cancer. According to the American Cancer Society, one in three people in the U.S. are affected by the disease1. And while our Oncology team works every day to find new therapies and treatments for various forms of cancer, Pfizer’s commitment to help end cancer doesn’t stop at the lab door. It includes financial support and colleague participation in community groups and events. Pfizer was...
Pfizer’s Plans to Celebrate Juneteenth 2023
Credit: Lightship Dedication to nurturing diversity, equity, and inclusion is crucial at Pfizer, as it is for many businesses. In fact, equity is one of Pfizer’s four core values, and we strive for it for those within Pfizer and for patients around the globe. It’s in this spirit that Pfizer is proud to not only recognize Juneteenth and its historical significance, but also celebrate it through our actions and our engagement with the community. Long observed by many for many years, Juneteenth...
ASCO 2023: Partnering with Patients to Bring an End to Cancer
Credit: © ASCO, Scott Morgan From June 2-6, the world’s oncology community came together for the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting to present the latest research and advances in cancer care. Including the sharing of exciting data, attracting one of our largest gatherings of cancer advocates, and recognizing the amazing innovations in cancer care, this year’s meeting, themed “Partnering with Patients: The Cornerstone of Cancer Care and Research,” reinforced...
Lady Gaga Partners with Pfizer to Raise Migraine Awareness
June is Migraine and Headache Awareness Month, and in keeping with this year’s theme, “Educate Yourself, Educate Others,” Pfizer is partnering with Lady Gaga to raise awareness of this often-misunderstood disease. Affecting about 40 million people in the United States and one billion people globally, migraine is a debilitating and recurrent neurological disease. In fact, according to one study, migraine is considered the second-most disabling condition in the world, following low back pain.1...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.